Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Escalation Study for the Evaluation of the Safety, Tolerability, and Pharmacokinetics of Recombinant Human Plasma Gelsolin (rhu-pGSN) Following Intravenous Administration to Healthy Volunteers.
Journal: Clinical pharmacology in drug development
Published: April 27, 2026
Blood-Borne Microparticles Are an Inflammatory Stimulus in Type 2 Diabetes Mellitus.
Journal: ImmunoHorizons
Published: December 14, 2022
Plasma gelsolin levels are associated with diabetes, sex, race, and poverty.
Journal: Journal of translational medicine
Published: December 09, 2022
Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease.
Journal: Atherosclerosis plus
Published: July 28, 2022
Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia.
Journal: Open forum infectious diseases
Published: May 09, 2022
Association of plasma gelsolin with frailty phenotype and mortality among octogenarian community-dwelling men: a cohort study.
Journal: Aging clinical and experimental research
Published: July 24, 2021
Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia.
Journal: Clinical infection in practice
Published: July 03, 2021
Plasma gelsolin modulates the production and fate of IL-1β-containing microparticles following high-pressure exposure and decompression.
Journal: Journal of applied physiology (Bethesda, Md. : 1985)
Published: March 25, 2021
An immune-based biomarker signature is associated with mortality in COVID-19 patients.
Journal: JCI insight
Published: September 22, 2020
Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease.
Journal: Inflammation
Published: June 18, 2020
Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia.
Journal: Antimicrobial agents and chemotherapy
Published: April 01, 2020
Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia.
Journal: Open forum infectious diseases
Published: March 18, 2020
Last Updated: 09/26/2026